Tag: carvedilol

1. In this randomized, placebo controlled study of HER2-positive breast cancer patients receiving trastuzumab, use of preventative lisinopril or carvedilol did not significantly reduce cardiotoxicity compared to placebo. 2. For patients undergoing therapy with trastuzumab combined with anthracyclines, use of either carvedilol or lisinopril was associated with a reduced risk...
1. Adding carvedilol to the management of patients with severe heart failure (NYHA Class III-IV and LVEF<25%) is associated with a 35% relative risk reduction in mortality. 2. In this patient population, carvedilol is also associated with decreased risk of hospitalization and serious adverse effects, as well as improvement in...